Viewing Study NCT00843050


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-01-02 @ 5:12 AM
Study NCT ID: NCT00843050
Status: TERMINATED
Last Update Posted: 2012-07-27
First Post: 2009-02-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
Sponsor: Piramal Enterprises Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-11
Start Date Type: None
Primary Completion Date: 2011-02
Primary Completion Date Type: ACTUAL
Completion Date: 2012-08
Completion Date Type: ESTIMATED
First Submit Date: 2009-02-12
First Submit QC Date: None
Study First Post Date: 2009-02-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2012-02-29
Results First Submit QC Date: None
Results First Post Date: 2012-07-27
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-06-20
Last Update Post Date: 2012-07-27
Last Update Post Date Type: ESTIMATED